Coverage
-
August 11, 2015
AbbVie Products LLC and other drugmakers being sued by the Federal Trade Commission and private plaintiffs over patent pay-for-delay settlements for testosterone drug AndroGel have told a Georgia federal court to reject a bid that would force them to turn over details of their settlement negotiations.
9 other articles on this case.
View all »